PROTEA CAPITAL SOLUTIONS
Protea Capital Solutions specializes in the financial industry with advanced software and payroll systems for businesses of all sizes.
PROTEA CAPITAL SOLUTIONS
Industry:
Credit Financial Services Software Technical Support
Founded:
2015-01-01
Address:
Pretoria, NA - South Africa, South Africa
Country:
South Africa
Website Url:
http://www.proteacs.com
Total Employee:
1+
Status:
Active
Contact:
+27 12 941 1572
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default Content Delivery Network Amazon JsDelivr Amazon Virginia Region Ruby On Rails Token TurboLinks Semantic UI
Similar Organizations
Hause Actuarial Solutions
Hause Actuarial Solutions specializes in product design, financial reports, actuarial software and other related services.
S.E.D.I.P.
SEDIP specializes in financial consultancy, company software, privacy advice and technical support to its clients.
More informations about "Protea Capital Solutions"
ProTAACS Remote Monitoring System
ProTAACS's family of Wireless, Wi-Fi, and PoE Low Temperature Sensors can help you remotely monitor a temperature range at +/- 0.5°C calibrated accuracy from -200°C to 0°C/-328°F to 32°F to help you keep valuable and vital assets …See details»
History and Reports – ProTAACS Product Catalog
If you do not generate a report in advance, ProTAACS still offers ways you can get your data in a CSV format. Feel free to contact ProTAACS. Support with further inquiries. Our Address. …See details»
Remote Monitoring Systems for Facility Monitoring – ProTAACS …
ProTAACS iPremier Live Page; MENU MENU. Customer Menu. Sensor Portal Login/Logout +62-21-39712506 / +62-814-13521050; [email protected]; MENU MENU. Customer …See details»
PROTACs: great opportunities for academia and industry (an
Jun 9, 2022 PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-degradation strategy that has emerged in recent years. It uses bifunctional small molecules to …See details»
proteanTecs - Company Profile - Tracxn
6 days ago proteanTecs - Provider of cloud-based lifecycle analytics software for chips. Raised a total funding of $175M over 4 rounds from 19 investors. Founded by Shai Cohen, Evelyn …See details»
PROTAC Technology: Opportunities and Challenges
Mar 12, 2020 PROTACs-induced targeted protein degradation has emerged as a novel therapeutic strategy in drug development and attracted the favor of academic institutions, large …See details»
PROTACs: Targeting breakdown of specific proteins to treat diseases
Sep 21, 2023 To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data …See details»
Mitacs: Bringing Innovation Into Reach - Mitacs
As Canada’s leading innovation organization, we connect businesses and researchers. We provide the resources needed to drive competitiveness and productivity in sectors such as …See details»
PROTACs: great opportunities for academia and industry (an
Jun 9, 2022 PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-degradation strategy that has emerged in recent years. It uses bifunctional small molecules to …See details»
PoE WaterLeak Sensor – ProTAACS Product Catalog
The ProTAACS Power-over-Ethernet (PoE) Water Rope Sensor detects conductive liquids anywhere along the length of the detection rope by using two wires covered with conducting …See details»
What are PROTACs and How Do They Treat Diseases? - NYAS
Jul 23, 2019 What makes PROTACs so unique? Most therapies are divided between small molecule inhibitors or therapeutic antibodies/biologics. However, “PROTACs are small …See details»
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Aug 14, 2020 The ubiquitin-proteasome system (UPS) is a key cellular machinery responsible for maintaining intracellular protein homeostasis (Finley, 2009; Hipp et al., 2019).Cellular …See details»
PROTACs: past, present and future - PubMed
Jun 20, 2022 Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules consisting of one ligand that binds to a protein of interest (POI) and another that can recruit an …See details»
What are PROTACs and How Do They Treat Diseases? - Bioss
Around 80% of disease-causing proteins, including key drivers of many cancers and other serious neurological conditions like Alzheimer‚Äôs disease, cannot be targeted by currently available …See details»
An overview of PROTACs: a promising drug discovery paradigm
Dec 20, 2022 Proteolysis targeting chimeras (PROTACs) technology has emerged as a novel therapeutic paradigm in recent years. PROTACs are heterobifunctional molecules that …See details»
PROTACs– a game-changing technology - PMC
Structures of E3 ligase degraders. 1.2.1. Cereblon (CRBN)-based degraders. In 2010, Ito et al. [] revealed that the molecular target and the primary cause of the teratogenic activity of …See details»
PoE Humidity Sensor – ProTAACS Product Catalog
The Power-over-Ethernet (PoE) Humidity (RH) Sensor accurately monitors the relative humidity of the air within a room orenclosure. Additionally, the iProTAACS Online Sensor Monitoring and …See details»
Solutions – ProTAACS Product Catalog
Tamini Square Jl. Taman Mini Blok SS33 No. 2 Jakarta Timur 13560, Indonesia +62-21-3971-2506See details»
An overview of PROTACs: a promising drug discovery paradigm
Dec 20, 2022 Proteolysis targeting chimeras (PROTACs) technology has emerged as a novel therapeutic paradigm in recent years. PROTACs are heterobifunctional molecules that …See details»
PROTACs: Current and Future Potential as a Precision Medicine
Apr 2, 2024 Proteolysis targeting chimeras (PROTAC) are an emerging precision medicine strategy, which targets key proteins for proteolytic degradation to ultimately induce cancer cell …See details»